ArticleDisability and health journal2022
A national profile of substance use disorder among Medicaid enrollees on the autism spectrum or with intellectual disability.
Article in Disability and health journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Disability-Related Differences in Substance Use Among U.S. Young Adults.Substance use & addiction journal · 2026Article
- Substance Use Disorder Outcomes and Treatment by Autism Status in Medicaid Enrollees With Substance Use Disorder.Autism research : official journal of the International Society for Autism Research · 2026Article
- Intersecting challenges: Substance use and mental health disparities across self-reported disability status.Journal of substance use and addiction treatment · 2026Article
- Comparing the prevalence of substance use disorders between persons with and without autism spectrum disorders.Autism : the international journal of research and practice · 2025Article
- Attention-Deficit/Hyperactivity Disorder in Medicaid-Enrolled Autistic Adults.JAMA network open · 2025Article
- Alcohol use among populations with autism spectrum disorder: narrative systematic review.BJPsych open · 2025Review
- Alcohol and Disability Sports: Insights from Swiss Coaches.Substance abuse and rehabilitation · 2025Article
- Autistic Traits, Emotion Regulation, Social Anxiety, Drinking to Cope, and Problematic Alcohol Use: A Cross-Cultural Examination Among Young Adults from Seven Countries.Substance use & misuse · 2025Article
- Mental health challenges faced by autistic people.Nature human behaviour · 2023Review
- Health conditions and service use of autistic women and men: A retrospective population-based case-control study.Autism : the international journal of research and practice · 2023Article
- Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2-Metabolome, immunome, synaptome.Frontiers in psychiatry · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundRecent research has questioned the assumption that people with intellectual disability (ID) or autism spectrum disorder (ASD) are less at risk of substance use disorders (SUDs). Overall, little is known about SUDs among people with intellectual and developmental disabilities (/IDDs).
objectiveThis study aimed to estimate prevalence of SUD among Medicaid enrollees with ASD, ID, or ASD + ID; characterize these groups and types of SUDs; and identify risk of SUD by demographic and clinical characteristics within groups.
methodsWe used 2008-2012 national Medicaid data to identify enrollees with ASD, ID, ASD + ID and a sample without ASD/ID and identified SUDs within these individuals. We used descriptive statistics to characterize enrollee groups and types of SUDs, calculated SUD prevalence, and used modified Poisson regression to examine adjusted relative risk of SUD within disability groups.
resultsSUD prevalence increased yearly across disability groups to 1-2.2%, increasing most quickly among those with ASD. Alcohol abuse was the most common SUD among those with ID-only (57%) versus cannabis abuse among the ASD-only group (41%). Risk of SUD was higher among those with co-occurring psychiatric disorders - notably, depression.
conclusionsResults highlight increasing prevalence of SUD among Medicaid enrollees with ASD-only and ASD + ID and higher risk of SUD among those with depression and other psychiatric disorders. Understanding access to screening, diagnosis and treatment of SUD among people with I/DDs is a highly important question for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.